Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
US |
|
C
|
Caesars Entertainment Inc
F:2ER
|
US |
|
Unity Bancorp Inc
F:UTB
|
US |
|
Actinium Pharmaceuticals Inc
F:7AY1
|
US |
|
T
|
Tesco PLC
BMV:TSCON
|
UK |
|
B
|
Best Buy Co Inc
F:BUY
|
US |
|
Koninklijke BAM Groep NV
AEX:BAMNB
|
NL |
|
G
|
Greencoat Renewables PLC
F:GRP
|
IE |
|
Gilead Sciences Inc
NASDAQ:GILD
|
US |
|
Lonza Group AG
SIX:LONN
|
CH |
Intrinsic Value
The intrinsic value for
Madrigal Pharmaceuticals Inc (MDGL) under the Base Case is hidden
USD.
Compared with the current market price of 544.51 USD, the stock appears hidden
.
MDGL looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if MDGL is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Madrigal Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Madrigal Pharmaceuticals Inc
Earnings Waterfall
Madrigal Pharmaceuticals Inc
The intrinsic value for
Madrigal Pharmaceuticals Inc (MDGL) under the Base Case is hidden USD.
Compared with the current market price of 544.51 USD, the stock appears hidden.